Browsing
     by title


0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

or enter first few letters:   
OK
See detailEpidemiology and familiarity
Beckers, Albert ULg

Scientific conference (2009, November)

Detailed reference viewed: 3 (0 ULg)
See detailEpidemiology and genetics of FIPA
Beckers, Albert ULg

Scientific conference (2011, November 18)

Detailed reference viewed: 8 (0 ULg)
See detailEpidemiology and genetics of FIPA
Beckers, Albert ULg

in 15th annual Canadian Society of Endocrinology and metabolism - Abstract book (2012, October)

Detailed reference viewed: 10 (4 ULg)
Full Text
See detailEpidemiology and genetics of FIPA
Beckers, Albert ULg

Scientific conference (2011, June 06)

Detailed reference viewed: 26 (10 ULg)
See detailEpidemiology and genetics of FIPA
Beckers, Albert ULg

in 12th ESE PostGraduate Course in Clinical Endocrinology - Abstract book (2012)

Detailed reference viewed: 10 (0 ULg)
See detailEpidemiology and Genetics of pituitary adenomas
Beckers, Albert ULg

Scientific conference (2009, March 02)

Detailed reference viewed: 4 (0 ULg)
See detailEpidemiology and genetics of pituitary adenomas
Beckers, Albert ULg

Scientific conference (2014, March 14)

Detailed reference viewed: 7 (0 ULg)
See detailEpidemiology and Genetics of pituitary adenomas
Beckers, Albert ULg

Scientific conference (2009, May 01)

Detailed reference viewed: 5 (0 ULg)
Full Text
Peer Reviewed
See detailThe epidemiology and genetics of pituitary adenomas.
Daly, Adrian ULg; Tichomirowa, M. A.; Beckers, Albert ULg

in Best Practice & Research. Clinical Endocrinology & Metabolism (2009), 23(5), 543-554

According to data derived from autopsy and radiological imaging series, pituitary tumours occur very commonly in the general population; however, most of these tumours are incidental findings with no ... [more ▼]

According to data derived from autopsy and radiological imaging series, pituitary tumours occur very commonly in the general population; however, most of these tumours are incidental findings with no obvious clinical impact. The historical data on the prevalence of pituitary adenomas in the clinical setting are scant and point to such tumours being relatively rare. Recent studies have shown that the prevalence of clinically relevant pituitary adenomas is 3-5 times higher than previously reported, which adds impetus to research into the aetiology of these tumours. Although the majority of pituitary adenomas are sporadic, approximately 5% of all cases occur in a familial setting and over half of these are due to Multiple Endocrine Neoplasia Type 1 (MEN-1) and Carney's Complex (CNC) disorders. Since the late 1990 s, we have described non-MEN1/CNC familial pituitary tumours that include all tumour phenotypes as a condition termed Familial Isolated Pituitary Adenomas (FIPAs). The clinical characteristics of the FIPAs vary from those sporadic pituitary adenomas, as patients with FIPAs have a younger age at diagnosis and larger tumours. About 15% of the FIPA patients have mutations in the aryl hydrocarbon receptor-interacting protein gene (AIP), which indicates that the FIPA may have a diverse genetic pathophysiology. [less ▲]

Detailed reference viewed: 31 (4 ULg)
See detailEpidemiology and genetics of pituitary tumors
Beckers, Albert ULg

Scientific conference (2007, February 01)

Detailed reference viewed: 3 (1 ULg)
See detailEpidemiology and genetics of pituitary tumors
Beckers, Albert ULg

Scientific conference (2013, February)

Detailed reference viewed: 17 (3 ULg)
See detailEpidemiology and genetics of pituitary tumors
Beckers, Albert ULg

Scientific conference (2007)

Detailed reference viewed: 2 (1 ULg)
Full Text
See detailEpidemiology and Genetics of Pituitary Tumours
Daly, Adrian ULg

Doctoral thesis (2008)

Detailed reference viewed: 16 (2 ULg)
See detailEpidemiology and genetics of pituitary tumours
Beckers, Albert ULg

in Chanson, Philippe (Ed.) Best Practice Research - Clinical Endocrinology and Metabolism (2008)

Detailed reference viewed: 8 (5 ULg)
Full Text
Peer Reviewed
See detailThe epidemiology and management of pituitary incidentalomas
Daly, Adrian ULg; Burlacu, M. C.; Livadariu, E. et al

in Hormone Research (2007), 68(Suppl. 5), 195-198

Prevalence: The prevalence of pituitary tumors has been a topic of controversy for many years. Autopsy and radiological series show that pituitary incidentalomas may be present in one of six people ... [more ▼]

Prevalence: The prevalence of pituitary tumors has been a topic of controversy for many years. Autopsy and radiological series show that pituitary incidentalomas may be present in one of six people. Recent epidemiological data suggest that clinically apparent pituitary adenomas have a prevalence of approximately one in 1,000 people in the general population. The disconnect between these two prevalence rates underlines the common clinical quandary of how to manage pituitary incidentalomas, particularly those lacking clinical signs/symptoms or hormonal abnormalities. Management: The natural history of incidentalomas suggests that periodic hormonal, clinical and radiological follow-up is the optimal approach. In the absence of tumor growth or relevant symptoms, screening can be continued intermittently or curtailed based on the clinical judgment of the physician. In the presence of hormonal hypersecretion, the management of pituitary incidentalomas, whether they are micro- or macroadenomas, should follow accepted clinical guidelines. For incidental pituitary macroadenomas without hormonal hypersecretion, clinical management should also include assessments for visual field impairment or hypopituitarism. In such cases, regular radiological and hormonal follow-up is required to identify tumor growth or the appearance of new symptoms. In the presence of tumor growth or new hormonal abnormalities, surgical options should be considered and discussed with the patient. Copyright (C) 2007 S. Karger AG, Basel. [less ▲]

Detailed reference viewed: 16 (7 ULg)
Full Text
Peer Reviewed
See detailEpidemiology and outcome of acute lung injury in European intensive care units. Results from the ALIVE study
Brun-Buisson, Christian; Minelli, Cosetta; Bertolini, Guido et al

in Intensive Care Medicine (2004), 30(1), 51-61

Abstract Objectives: To re-examine the epidemiology of acute lung injury (ALI) in European intensive care units (ICUs). Design and setting: A 2-month inception cohort study in 78 ICUs of 10 European ... [more ▼]

Abstract Objectives: To re-examine the epidemiology of acute lung injury (ALI) in European intensive care units (ICUs). Design and setting: A 2-month inception cohort study in 78 ICUs of 10 European countries. Patients: All patients admitted for more than 4 h were screened for ALI and followed up to 2 months. Measurements and main results: Acute lung injury occurred in 463 (7.1%) of 6,522 admissions and 16.1% of all mechanically ventilated patients; 65.4% cases occurred on ICU admission. Among 136 patients initially presenting with “mild ALI” (200< PaO2/FiO2 £300), 74 (55%) evolved to acute respiratory distress syndrome (ARDS) within 3 days. Sixty-two patients (13.4%) remained with mild ALI and 401 had ARDS. The crude ICU and hospital mortalities were 22.6% and 32.7% (p<0.001), and 49.4% and 57.9% (p=0.0005), respectively, for mild ALI and ARDS. ARDS patients initially received a mean tidal volume of 8.3±1.9 ml/kg and a mean PEEP of 7.7±3.6 cmH2O; air leaks occurred in 15.9%. After multivariate analysis, mortality was associated with age (odds ratio (OR) =1.2 per 10 years; 95% confidence interval (CI): 1.05–1.36), immuno-incompetence (OR: 2.88; Cl: 1.57–5.28), the severity scores SAPS II (OR: 1.16 per 10% expected mortality; Cl: 1.02–1.31) and logistic organ dysfunction (OR: 1.25 per point; Cl: 1.13–1.37), a pH less than 7.30 (OR: 1.88; Cl: 1.11–3.18) and early air leak (OR: 3.16; Cl: 1.59–6.28). Conclusions: Acute lung injury was frequent in our sample of European ICUs (7.1%); one third of patients presented with mild ALI, but more than half rapidly evolved to ARDS. While the mortality of ARDS remains high, that of mild ALI is twice as low, confirming the grading of severity between the two forms of the syndrome. [less ▲]

Detailed reference viewed: 6 (0 ULg)
See detailThe Epidemiology of Acromegaly
Beckers, Albert ULg; Daly, Adrian ULg

in John Wass (Ed.) Acromegaly book (2009)

Detailed reference viewed: 16 (1 ULg)
Full Text
See detailEpidemiology of atypical myopathy: descriptive phase
Votion, Dominique ULg; Linden, Annick ULg; Desmecht, Daniel ULg et al

in In Proceeding: First Scientific Symposium of the European College of Equine Internal Medicine (ECEIM) (2005, January)

Atypical myopathy (AM) in grazing horses is a frequently fatal condition that has been reported in several European countries. In Belgium, since autumn 2000, AM was confirmed in 39 equids based on ... [more ▼]

Atypical myopathy (AM) in grazing horses is a frequently fatal condition that has been reported in several European countries. In Belgium, since autumn 2000, AM was confirmed in 39 equids based on characteristic histological lesions in postural and respiratory muscles. This study describes the history, clinical signs and biochemical changes associated with AM in these confirmed cases. [less ▲]

Detailed reference viewed: 40 (6 ULg)
Full Text
See detailThe epidemiology of canine and feline obesity
Diez, Marianne ULg; Nguyen, Patrick

in Waltham Focus Dog and cat obesity (2006), 1

Detailed reference viewed: 263 (0 ULg)